Augmentation of clozapine's antiagressive properties with lamotrigine in a patient with chronic disorganized schizophrenia
ZM Pavlovic - Journal of clinical psychopharmacology, 2008 - journals.lww.com
To the Editors: On May 2, 2007, the US Food and Drug Administration expanded black box
warnings of all antidepressant medications to include information about an increased risk of …
warnings of all antidepressant medications to include information about an increased risk of …
Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine
T Inoue, M Honda, K Kawamura, K Tsuchiya… - Progress in Neuro …, 2012 - Elsevier
This study was undertaken to examine the long-term effectiveness and safety of switching to
sertraline from other selective serotonin reuptake inhibitors (SSRIs) in the treatment of non …
sertraline from other selective serotonin reuptake inhibitors (SSRIs) in the treatment of non …
Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression
This study assessed the effect of general medical comorbidity on response to next-step
antidepressant treatments among subjects with major depressive disorder whose …
antidepressant treatments among subjects with major depressive disorder whose …
Small numbers, big impact
JW Smoller, AA Nierenberg - Harvard review of psychiatry, 1999 - journals.lww.com
In 1990 a report appeared in the American Journal of Psychiatry1 concerning six patients
with a history of depression who developed “intense, violent suicidal preoccupation” during …
with a history of depression who developed “intense, violent suicidal preoccupation” during …
[HTML][HTML] The search for improved antidepressant strategies: is bigger better?
W Coryell - American Journal of Psychiatry, 2011 - Am Psychiatric Assoc
Despite a proliferation of pharmaceutical options for the treatment of major depression over
the past 20 years, reported remission rates among patients given antidepressants have …
the past 20 years, reported remission rates among patients given antidepressants have …
[HTML][HTML] The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report
A Kishimoto, A Todani, J Miura, T Kitagaki… - Annals of General …, 2010 - Springer
Background Psychotic major depression is a clinical subtype of major depressive disorder. A
number of clinical studies have demonstrated the efficacy of the combination of an …
number of clinical studies have demonstrated the efficacy of the combination of an …
Symptom remission in OCD after discontinuation of pharmacotherapy with fluoxetine: A case for looking beyond serotonin
B Zurowski, K Wahl, F Hohagen, A Kordon - Progress in Neuro …, 2007 - Elsevier
3. Discussion The time course of this symptom remission approximately 1 week after
fluoxetine discontinuation is strikingly consistent with the pharmacokinetics of fluoxetine …
fluoxetine discontinuation is strikingly consistent with the pharmacokinetics of fluoxetine …
Platelet function and sertraline
SD Mendelson - American Journal of Psychiatry, 2001 - Am Psychiatric Assoc
To the Editor: It was dismaying to read the article by Jerome H. Markovitz, MD, MPH, et al.(1)
concerning platelet function in depressed subjects before and after sertraline treatment …
concerning platelet function in depressed subjects before and after sertraline treatment …
Effective treatment of venlafaxine-induced noncyclical mastalgia with bromocriptine
SC Bhatia, SK Bhatia, L Bencomo - Journal of Clinical …, 2000 - journals.lww.com
Venlafaxine, a novel antidepressant, selectively inhibits the neuronal reuptake of serotonin
and norepinephrine and is a weak reuptake inhibitor of dopamine. It has been reported to …
and norepinephrine and is a weak reuptake inhibitor of dopamine. It has been reported to …